<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>NICE CKS – Balanitis Quick Reference</title>
<meta name="viewport" content="width=device-width, initial-scale=1">
<style>
:root{
  --brand:#005EB8;
  --brand-light:#E8F2FF;
  --text:#111;
  --bg:#f7f9fc;
  --card:#fff;
  --border:#e0e6ed;
  --shadow:0 2px 8px rgba(0,0,0,.06);
  --radius:8px;
  --font:"Segoe UI",Roboto,"Helvetica Neue",Arial,sans-serif;
}
*{box-sizing:border-box;margin:0;padding:0}
body{
  font-family:var(--font);
  background:var(--bg);
  color:var(--text);
  line-height:1.5;
}
header{
  background:var(--brand);
  color:#fff;
  padding:1.5rem 2rem;
  display:flex;
  align-items:center;
  gap:1rem;
}
header img{height:40px}
header h1{font-size:1.5rem;font-weight:600}
main{max-width:1200px;margin:2rem auto;padding:0 1rem;display:grid;gap:2rem}
section{
  background:var(--card);
  border:1px solid var(--border);
  border-radius:var(--radius);
  box-shadow:var(--shadow);
  padding:1.5rem;
}
h2{
  font-size:1.25rem;
  margin-bottom:1rem;
  color:var(--brand);
  display:flex;
  align-items:center;
  gap:.5rem;
}
h2 svg{width:24px;height:24px;fill:var(--brand)}
ul{list-style:none}
li{margin-bottom:.5rem}
li strong{color:var(--brand)}
table{width:100%;border-collapse:collapse;font-size:.9rem}
th,td{padding:.75rem;border-bottom:1px solid var(--border);text-align:left}
th{background:var(--brand-light)}
a{color:var(--brand);text-decoration:none}
a:hover{text-decoration:underline}
footer{
  text-align:center;
  font-size:.75rem;
  color:#555;
  padding:1rem;
}
@media(max-width:600px){
  h1{font-size:1.25rem}
  th,td{font-size:.8rem;padding:.5rem}
}
</style>
</head>
<body>

<header>
  <!-- NICE SVG logo (inline) -->
  <svg aria-hidden="true" width="40" height="40" viewBox="0 0 100 100">
    <circle cx="50" cy="50" r="45" fill="#fff"/>
    <text x="50" y="56" text-anchor="middle" font-size="40" fill="#005EB8" font-weight="700">N</text>
  </svg>
  <h1>NICE CKS – Balanitis Quick Reference Guide</h1>
</header>

<main>
  <!-- Overview -->
  <section>
    <h2>
      <svg aria-hidden="true" viewBox="0 0 24 24"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm-2 15l-5-5 1.41-1.41L10 14.17l7.59-7.59L19 8l-9 9z"/></svg>
      Overview
    </h2>
    <p>This page distils the NICE CKS balanitis topic (May 2024) into an at-a-glance algorithm for primary-care clinicians.</p>
  </section>

  <!-- Algorithm -->
  <section>
    <h2>
      <svg aria-hidden="true" viewBox="0 0 24 24"><path d="M9 11H7v2h2v-2zm4 0h-2v2h2v-2zm4 0h-2v2h2v-2zm2-7h-1V2h-2v2H8V2H6v2H5c-1.11 0-2 .9-2 2v14c0 1.1.89 2 2 2h14c1.1 0 2-.9 2-2V6c0-1.1-.9-2-2-2zm0 16H5V9h14v11z"/></svg>
      4-Step Algorithm
    </h2>
    <ol>
      <li><strong>Suspect</strong> – Typical symptoms + risk factors.</li>
      <li><strong>Assess</strong> – History, examination, red-flag check.</li>
      <li><strong>Test</strong> – Swab / STI screen / HbA1c as indicated.</li>
      <li><strong>Treat & Review</strong> – Empiric therapy below; refer if recalcitrant or red-flag.</li>
    </ol>
  </section>

  <!-- Treatment Table -->
  <section>
    <h2>
      <svg aria-hidden="true" viewBox="0 0 24 24"><path d="M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zm0 16H5V5h14v14zM7 10h2v2H7zm4-4h2v6h-2zm4 2h2v4h-2z"/></svg>
      Empiric Management
    </h2>
    <table>
      <thead>
        <tr><th>Probable Cause</th><th>First-Line Therapy</th></tr>
      </thead>
      <tbody>
        <tr><td>Irritant / non-specific</td><td>Good hygiene, lukewarm wash, emollient</td></tr>
        <tr><td>Dermatitis / allergy</td><td>Hydrocortisone 1 % od ≤ 14 d + imidazole if Candida</td></tr>
        <tr><td>Candidal</td><td>Imidazole cream 2–3×/d 2 wk<br>OR fluconazole 150 mg single dose (severe)</td></tr>
        <tr><td>Bacterial – mild</td><td>Mupirocin 2 % topical 2–3×/d 7–10 d</td></tr>
        <tr><td>Bacterial – severe</td><td>Phenoxymethylpenicillin 500 mg qds 10 d<br>Clarithromycin 250 mg bd 7 d if penicillin-allergic</td></tr>
        <tr><td>Anaerobic (Gardnerella)</td><td>Metronidazole 400 mg bd 7 d</td></tr>
      </tbody>
    </table>
  </section>

  <!-- Referral -->
  <section>
    <h2>
      <svg aria-hidden="true" viewBox="0 0 24 24"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z"/></svg>
      Referral Indications
    </h2>
    <ul>
      <li>Diagnosis uncertain / biopsy needed</li>
      <li>Recalcitrant or recurrent disease</li>
      <li>Suspected lichen sclerosus, Zoon’s, neoplasia</li>
      <li>Penile mass / persistent ulcer → 2-week wait</li>
      <li>Severe phimosis / paraphimosis</li>
    </ul>
  </section>

  <!-- Pearls -->
  <section>
    <h2>
      <svg aria-hidden="true" viewBox="0 0 24 24"><path d="M12 2l3.09 6.26L22 9.27l-5 4.87 1.18 6.88L12 17.77l-6.18 3.25L7 14.14 2 9.27l6.91-.01L12 2z"/></svg>
      Quick Pearls
    </h2>
    <ul>
      <li>Retract & gently dry foreskin daily.</li>
      <li>Avoid soap, bubble bath, latex condoms during flare.</li>
      <li>Consider circumcision for repeated lichen sclerosus.</li>
      <li>Screen partners for streptococcal balanitis.</li>
    </ul>
  </section>
</main>

<footer>
  Source: NICE Clinical Knowledge Summaries – Balanitis (May 2024).<br>
  © Clarity Informatics trading as Agilio Software.
</footer>

</body>
</html>